CID 135565884

Zanubrutinib

Structural Information

Molecular Formula
C27H29N5O3
SMILES
C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N
InChI
InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1
InChIKey
RNOAOAWBMHREKO-QFIPXVFZSA-N
Compound name
(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

198
References

4246
Patents

471.22705 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 472.23433 215.1
[M+Na]+ 494.21627 226.2
[M+NH4]+ 489.26087 219.3
[M+K]+ 510.19021 221.8
[M-H]- 470.21977 219.7
[M+Na-2H]- 492.20172 220.2
[M]+ 471.22650 217.5
[M]- 471.22760 217.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe